Sema4 Holdings Corp Equity-NMS: SMFR

Healthcare

Health Information Services

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$2.03

52W high :

$12.65

1Y :

-82.75%

5Y :

-77.86%

Shares O/S :

377.25 M

Market cap :

696.02 M

What is the share price of Sema4 Holdings Corp today?

Sema4 Holdings Corp (SMFR) share price as of August 9, 2022, is $0. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sema4 Holdings Corp?

Yes, Indian Investors can invest in the Sema4 Holdings Corp (SMFR) Share by opening an international trading account with Angel One.

How can I purchase Sema4 Holdings Corp shares in India?

Purchasing Sema4 Holdings Corp (SMFR) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Sema4 Holdings Corp (SMFR) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sema4 Holdings Corp?

Yes, you can purchase fractional shares of Sema4 Holdings Corp (SMFR) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sema4 Holdings Corp?

The market capitalization of Sema4 Holdings Corp on August 9, 2022, is $701.68 M.

In which sector Sema4 Holdings Corp belongs?

Sema4 Holdings Corp operates in the Healthcare sector, specifically in the Health Information Services industry.

What documents are required to invest in Sema4 Holdings Corp stocks?

In order to invest in Sema4 Holdings Corp (SMFR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Sema4 Holdings Corp., formerly CM Life Sciences Inc., is a patient-centered health intelligence company that is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence and machine learning to clinical and genomic data to build models of human health and define individualized health trajectories. The Company’s health intelligence platform, Centrellis enables users to generate a complete understanding of disease and wellness and to provide science-driven solutions to pressing medical needs. Its Expanded Carrier Screen (ECS) is a carrier screen for inherited conditions. Its Noninvasive Prenatal Testing Solutions is a test that screens for autosomal and sex chromosome aneuploidies. Its Natalis Newborn Screening Solutions is a test of its screening portfolio allowing for detection of heritable conditions from pre-conception, pregnancy and childhood. The Company also includes Signal Precision Oncology Solutions.